A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF
article
OA: closed
CC0
⤵ 23 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study compared two months of GnRH agonist pretreatment with or without an aromatase inhibitor in women with ovarian endometriomas undergoing IVF.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (34)
- Advances in the medical management of endometriosis via openalex
- Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? via openalex
- Aromatase inhibitors for the treatment of endometriosis via openalex
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex
- Endometrial and Endometriotic Concentrations of Estrone and Estradiol Are Determined by Local Metabolism Rather than Circulating Levels via openalex
- Endometriosis and Assisted Reproductive Technologies: Maximizing Outcomes via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Gonadotropin-Releasing Hormone Agonists for Endometriosis via openalex
- Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis via openalex
- New developments in the medical treatment of endometriosis via openalex
- Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas via openalex
- Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist via openalex
- Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis via openalex
- Treatment of endometrioma for improving fertility via openalex
- W2277353857 via openalex
- W2041530351 via openalex
- W2041167474 via openalex
- W2750946304 via openalex
- W2020432759 via openalex
- W2972999179 via openalex
- W1764416709 via openalex
- W6632812256 via openalex
- W2079190330 via openalex
- W6684855666 via openalex
- W2075153820 via openalex
- W2139304464 via openalex
- W2066865081 via openalex
Cited by (23)
- Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes 2025
- Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes 2025
- Global Trends and Emerging Frontiers on Ovarian Endometriosis: A Bibliometric and Visualization Analysis 2025
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- Evidence based management of patients with endometriosis undergoing assisted conception: British fertility society policy and practice recommendations 2024
- How to Protect Fertility Potential in Endometriosis 2024
- Postoperative Reproductive Outcomes in Patients with Endometriosis-Associated Infertility: A Single-Center Retrospective Study 2024
- Outpatient diagnosis and drug therapy of endometriosis: A review 2024
- Additional file 1 of Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis 2024
- Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
- Additional file 2 of Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis 2024
- Additional file 1 of Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis 2024
- Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis 2024
- Additional file 2 of Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis 2024
- Low-dose letrozole – an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- Endometriosis, Oocyte, and Embryo Quality 2023
- Expectant, Medical, and Surgical Management of Ovarian Endometriomas 2023
- Endometriosis, Oocyte and Embryo Quality 2023
- Spécificités de la prise en charge en assistance médicale à la procréation 2022
- Fertility Preservation in Endometriosis 2022
- Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects 2021
- The role of pharmacotherapy in the treatment of endometriosis across the lifespan 2020
- Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:54.901233+00:00
License: CC0
· commercial use OK